Eric Cantor Named CEO of Pharma Lobby Group PhRMA Amid Pricing Scrutiny
Former House GOP-majority leader Eric Cantor has been appointed CEO of PhRMA, the leading U.S. drug-industry lobbying organization.
Eric Cantor, who previously served as the Republican leader in the House, will take over as chief executive of PhRMA. The move comes as the group confronts growing political pressure over drug-price reforms. One outlet administration is working to turn voluntary pricing deals with dozens of manufacturers into law, while Democrats push for broader price-comparison mechanisms in Medicare.
Why it matters
PhRMA's leadership change could shape how the drug industry responds to intense U.S. price-control efforts.
In this story
Eric CantorPhRMAdrug pricingpharmaceutical lobbyingU.S. CongressMedicareprice reforms
